7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cerebral Blood Flow and Metabolism
Cerebral Blood Flow : CBF is explained as the blood volume that flows per unit mass per unit time in brain tissue and is typically indicates in units of ml blood. Direct methods for calculating CBF in human subjects include single-photon emission computed tomography (SPECT), positron emission tomography (PET), MRI with contrast agents, and arterial spin labeling (ASL) MRI.
CBF is controlled by four major mechanisms:
- Metabolic control (or 'metabolic autoregulation')
- Pressure autoregulation.
- Chemical control (by arterial pCO2 and pO2)
- Neural control.
Metabolism: Metabolism is used to express all chemical reactions included in continuing the living state of the cells and the organism. Metabolism can be efficiently divided into two categories: Catabolism and Anabolism. Catabolism refers to the breakdown of molecules to obtain energy and Anabolism refers to the synthesis of all compounds needed by the cells.
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United StatesSubmit your abstract Today
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical School, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Successful treatment of sinus of valsalva aneurysm
Aina Jarillo, Universidad Anahuac Mexico Norte, Mexico
Title : Metabolic and echocardiographic predictors of ventricular extrasystoles burden in non-ischemic patients
Ahmed Ahmed Mohamed Hassan, Al-Azhar Medical School, Egypt